Leflunomide‐induced liver injury: Differences in characteristics and outcomes in Indian and US registries
Sign Up to like & getrecommendations! Published in 2022 at "Liver International"
DOI: 10.1111/liv.15189
Abstract: Leflunomide, a disease‐modifying anti‐rheumatic drug, has been associated with elevations of serum aminotransferases. Herein, we describe the clinical, laboratory features and outcomes of 17 patients with leflunomide/teriflunomide hepatotoxicity from two large drug‐induced liver injury (DILI)… read more here.
Keywords: injury differences; differences characteristics; liver injury; induced liver ... See more keywords